[1]陈燕中,宋仲涛,丘文凤.银杏叶提取物和经皮球囊压迫术治疗三叉神经痛研究进展[J].陕西医学杂志,2024,(10):1438-封3.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.031]
　CHEN Yanzhong,SONG Zhongtao,QIU Wenfeng.Research progress of ginkgo biloba extract and percutaneous balloon compression in treatment of trigeminal neuralgia[J].,2024,(10):1438-封3.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.031]
点击复制

银杏叶提取物和经皮球囊压迫术治疗三叉神经痛研究进展
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年10期
页码:
1438-封3
栏目:
综 述
出版日期:
2024-10-05

文章信息/Info

Title:
Research progress of ginkgo biloba extract and percutaneous balloon compression in treatment of trigeminal neuralgia
作者:
陈燕中; 宋仲涛; 丘文凤
(梅州市人民医院疼痛科,广东 梅州 514031)
Author(s):
CHEN Yanzhong; SONG Zhongtao; QIU Wenfeng
(Department of Pain,Meizhou People's Hospital,Meizhou 514031,China)
关键词:
银杏叶提取物;  经皮球囊压迫术;  三叉神经痛;  疗效;  研究进展
Keywords:
Ginkgo biloba extract;  Percutaneous balloon compression;  Trigeminal neuralgia;  Curative effect;  Research progress
分类号:
R 745.1
DOI:
DOI:10.3969/j.issn.1000-7377.2024.10.031
文献标志码:
A
摘要:
三叉神经痛的病因目前普遍分为两种,即原发性和继发性。原发性三叉神经痛尚无明确具体的发病机制,主要临床症状是面部三叉神经分布区内无固定规律反复发生的剧烈痛感,使患者遭受极大痛苦,生活质量严重降低。目前临床治疗三叉神经痛的主要手术方式中,经皮球囊压迫术能够对患者的疼痛进行有效缓解,是安全、简单、有效的治疗三叉神经痛的首要手术方式。银杏叶提取物富含多种有机酸,能够对三叉神经痛患者的神经功能起到保护和恢复作用。本文综述了经皮球囊压迫术和银杏叶提取物在三叉神经痛治疗中的应用效果,旨在为临床三叉神经痛的治疗提供一定文献依据和参考。
Abstract:
The causes of trigeminal neuralgia can be generally divided into two types,primary and secondary,and the pathogenesis of primary trigeminal neuralgia is not yet clear.The major clinical symptom is the intense pain that occurs consistently,irregularly and repeatedly in the facial trigeminal nerve distribution area,and trigeminal neuralgia patients suffer very much and the quality of life is severely lowered.Among the current mainstream surgical methods in the clinical treatment of trigeminal neuralgia,percutaneous balloon compression is a safe,simple and effective surgical method of trigeminal neuralgia as it can effectively relieve patient pain.Ginkgo biloba extract is rich in various organic acids,which acts to protect and restore the nerve function of patients with trigeminal neuralgia.This paper attempts to sum up the application effect of percutaneous balloon compression and ginkgo biloba extract in the treatment of trigeminal neuralgia,so as to provide certain reference for the treatment of trigeminal neuralgia.

参考文献/References:

[1] 王佳林,葛忆秦.原发性三叉神经痛的治疗研究进展[J].世界临床药物,2023,44(6):542-546.
[2] 郭楠,汪秀玲.原发性三叉神经痛的MRI研究进展[J].放射学实践,2021,36(7):942-946.
[3] 邓浩,罗星,石采灵,等.三叉神经痛琼脂压迫模型优化及相关解剖结构学研究[J].中国疼痛医学杂志,2023,29(11):815-823.
[4] BATAWI A H.Ginkgo biloba extract mitigates the neurotoxicity of AlCl3 in alzheimer rat's model:role of apolipoprotein E4 and clusterin genes in stimulating ROS generation and apoptosis[J].Int J Neurosci,2024,134(1):34-44.
[5] ASIWE J N,OJETOLA A A,EKENE N E,et al.Pleiotropic attenuating effect of Ginkgo biloba against isoprenaline-induced myocardial infarction via improving Bcl-2/mTOR/ERK1/2/Na+,K+-ATPase activities[J].Chin Herb Med,2023,16(2):282-292.
[6] 陈璟,杨小艺,陈静,等.银杏叶提取物对糖尿病肾病模型小鼠肾脏炎症的抑制作用及机制[J].中国药房,2024,35(2):186-191.
[7] 吴勇,吴应林,汪声奎.银杏内酯注射液辅助治疗老年缺血性脑卒中的疗效及对患者神经功能和预后的影响[J].河北医药,2020,42(15):2291-2295.
[8] 陈娇,周娟,王娟,等.丁苯酞软胶囊联合银杏叶提取物注射液治疗急性脑梗死患者临床效果观察[J].临床军医杂志,2023,51(7):713-715,721.
[9] 刘娜,尹丽鹤,赵钢.银杏叶提取物联合前列地尔治疗中枢性眩晕疗效及对患者血液流变学的影响[J].陕西中医,2020,41(7):868-870.
[10] 冀桂苗,张亚娟,付水鸽,等.丁苯酞联合银杏叶提取物对急性缺血性脑卒中患者血流动力学及血清神经营养因子的影响分析[J].中国合理用药探索,2024,21(1):79-86.
[11] 程晶.银杏叶提取物中复合成分的药理活性分析[J].化工设计通讯,2023,49(9):184-186.
[12] 李超,熊兰,卢元明.银杏叶提取物联合茴拉西坦治疗血管性痴呆疗效观察[J].陕西医学杂志,2023,52(6):737-740.
[13] 吴民民,刘小华,陈小雨,等.浮针配合再灌注治疗原发性三叉神经痛临床研究[J].陕西中医,2021,42(5):646-649,653.
[14] YU X,LIANG Y.Clinical efficacy of percutaneous balloon compression combined with carbamazepine in the treatment of trigeminal neuralgia:A retrospective study[J].Ann Ital Chir,2024,95(2):200-205.
[15] PENG Y,ZOU C,LI Y,et al.Balloon pressure and clinical effectiveness of percutaneous microballoon compression in the treatment of primary trigeminal neuralgia[J].Pain Physician,2024,27(3):e345-e353.
[16] 夏英华,闵飞祥,余桂,等.球囊压迫术与微血管减压术治疗原发性三叉神经痛的对比研究[J].中国疼痛医学杂志,2024,30(4):274-281.
[17] 张鸿昊,蒋宗滨,吕旌,等.首次经皮球囊压迫术与射频热凝术后再行经皮球囊压迫术治疗三叉神经痛的比较[J].中南大学学报(医学版),2024,49(1):40-46.
[18] 沈志远,刘雨昂,王常州,等.三叉神经痛球囊压迫术后复发的影响因素分析[J].徐州医科大学学报,2024,44(2):124-130.
[19] 夏英华,闵飞祥,余桂,等.球囊压迫术与微血管减压术治疗原发性三叉神经痛的对比研究[J].中国疼痛医学杂志,2024,30(4):274-281.
[20] 张媛婧,王稳,刘春华,等.经皮微球囊压迫术和射频热凝术治疗原发性三叉神经痛的有效性和安全性研究[J].中国疼痛医学杂志,2024,30(3):183-188.
[21] 张焕焕,张延红.老年患者行三叉神经半月节球囊压迫术诱发自主神经反射致心脏停搏1例报告[J].北京医学,2024,46(3):255-258.
[22] 齐亮,刘文广,郑金玉,等.构建模型预测经皮球囊压迫治疗后三叉神经痛复发[J].中国介入影像与治疗学,2024,21(4):206-210.
[23] 李春辉,朱骁,陈涛,等.经皮穿刺球囊压迫术球囊压力与三叉神经痛疗效和并发症的相关性研究[J].中国微侵袭神经外科杂志,2020,25(11):489-492.
[24] 沈志远,刘雨昂,王常州,等.三叉神经痛球囊压迫术后复发的影响因素分析[J].徐州医科大学学报,2024,44(2):124-130.
[25] 尹姬,刘诤,师昕翌,等.C臂CT在经皮三叉神经痛球囊压迫术中的应用价值[J].介入放射学杂志,2023,32(8):755-759.
[26] 李传胜,王昆鹏,杨婕,等.个体因素对经皮穿刺球囊压迫术治疗原发性三叉神经痛疗效的影响[J].河北医学,2023,29(7):1142-1149.
[27] 张庚,寿记新,王冰冰,等.经皮穿刺微球囊压迫术(两次压迫法)治疗复发性三叉神经痛的疗效分析[J].中国疼痛医学杂志,2023,29(2):144-148.
[28] 张娇,周茜,李萌,等.显微血管减压术、经颅电刺激以及球囊压迫术治疗三叉神经痛临床对比研究[J].陕西医学杂志,2023,52(4):414-417,427.
[29] ZHANG H,JIANG Z,LÜ J,et al.Comparison of initial percutaneous balloon compression versus radiofrequency thermocoagulation followed by percutaneous balloon compression in the treatment of trigeminal neuralgia[J].Zhong Nan Da Xue Xue Bao Yi Xue Ban,2024,49(1):40-46.
[30] 李锴,刘德中,王常伟,等.经皮穿刺微球囊压迫术治疗原发性三叉神经痛并发症的危险因素分析[J].中国临床神经外科杂志,2019,24(3):153-154,158.
[31] 刘振波,王明宇,连世忠.微球囊压迫术与微血管减压术治疗三叉神经痛的疗效及不良反应评估[J].神经损伤与功能重建,2023,18(4):197-200.
[32] 杨迎慧,赵姗,王雅娇,等.改良3D数字化导板辅助穿刺在微球囊压迫术治疗原发性三叉神经痛中的应用[J].口腔疾病防治,2023,31(8):559-566.
[34] 罗似亮,张明亮,吾太华,等.影像引导下经皮半月节球囊压迫术治疗原发性三叉神经痛50例分析[J].临床神经外科杂志,2023,20(5):566-568,574.
[35] 樊肖冲,徐富兴,邢飞,等.经皮穿刺微球囊压迫术治疗手术后复发性三叉神经痛及其负性情绪的疗效分析[J].郑州大学学报(医学版),2021,56(1):77-80.
[36] 何宝岩,高乃康,徐成伟.经皮三叉神经半月节球囊压迫术治疗三叉神经痛临床分析[J].内蒙古医科大学学报,2023,45(3):283-286.

备注/Memo

备注/Memo:
基金项目:广东省梅州市医药卫生科研课题(2023-B-27)
更新日期/Last Update: 2024-10-08